ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS

The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteur: R.T. Saygitov
Formaat: Artikel
Taal:English
Gepubliceerd in: "Paediatrician" Publishers LLC 2008-08-01
Reeks:Вопросы современной педиатрии
Online toegang:https://vsp.spr-journal.ru/jour/article/view/1441

Gelijkaardige items